Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-PRF and Hyaluronic Acid in TMJ Internal Derangement
NCT07373730Completed
- Sponsor
- Suez Canal University
- Start
- Aug 2023
- Primary completion
- Jun 2024
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial of platelet rich fibrin in temporomandibular joint internal derangement (TMJID) (2 arms), sponsored by Suez Canal University. Primary endpoints: Maximum mouth opening at 6 months, Lateral to Right movement at 6 months and 4 more. Started Aug 2023; status: completed.
02
Drugs
platelet rich fibrin
03
Conditions
temporomandibular joint internal derangement (TMJID)
Beyond the preview
Go deeper on NCT07373730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07373730.